Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2020-03-26 | 2020-04-23 | 109574 |
TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2020-09-03 | 2021-02-05 | 123738 |
TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2023-10-26 | 2023-11-09 | 208251 |
ZESTORETIC | 12.5MG 10MG | TABLET | Resolved | 2023-06-19 | 2023-07-13 | 195535 |
ZESTORETIC | 10MG 12.5MG | TABLET | Actual shortage | 2023-08-24 | 2023-12-05 | 202917 |
ZESTORETIC | 10MG 12.5MG | TABLET | Resolved | 2023-09-15 | 2023-09-20 | 204548 |
ZESTORETIC | 12.5MG 20MG | TABLET | Resolved | 2023-08-02 | 2023-08-03 | 200688 |
ZESTORETIC | 12.5MG 20MG | TABLET | Resolved | 2023-11-28 | 2024-01-23 | 211672 |
VISKAZIDE | 25MG 10MG | TABLET | Resolved | 2021-12-15 | 2022-04-27 | 151232 |
VISKAZIDE | 50MG 10MG | TABLET | Resolved | 2021-12-15 | 2022-04-27 | 151235 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
RAMIPRIL-HCTZ | Discontinued | 2018-12-21 | 2018-12-22 | 70392 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 |